Upcoming workshop organized by the Peoples’ Science Centre, MANT, on 24th February 2024. The workshop will enable the voice of tribal populations in West Bengal to reach the state policymakers through workshop dialogue, workshop report synthesis, and policy briefs.
Webinar on Global Evidence, Local Decisions
Event Date: June 9, 2023
The JBI gLOCAL Solution Room was a ten-day event held across the globe from 05 – 11 June 2023, in numerous different countries and was designed to provide pragmatic solutions to challenges in getting evidence into practice in clinical setting.
Each JBI gLOCAL Solution Room event included a panel of experts giving ‘real- world’ insights during their presentations focused on evidence-implementation. As a ‘think tank’ they then responded directly to participant questions around Evidence Based Practice (EBP) challenges in an interactive panel discussion. The aim was to provide practical solutions for getting evidence into practice in your clinical setting.
The JBI gLOCAL Solution Room aimed to bring together clinicians, academics, and policymakers interested in evidence-based healthcare and served as a synchronized, collaborative, and widely accessible inter-regional space to promote evidence-based practice discussion and debate. Attendance to all events worldwide was free of charge. Learn more about ‘GLOCALization’ and JBI’s approach to global evidence-based healthcare at jbi.global/jbisolutionroom
PROGRAMME SCHEDULE | |
SESSION 1 | Chairperson: Ms Mpho Maimane JBI- Ekurhuleni |
13:30-13:45 | Welcome: Mr Terrance Magorro, Chairperson JBI Ekurhuleni Advisory Board |
13:45- 14:00 | Introduction to JBI Prof Denny John: Co-Director: JBI-CPHR |
SESSION 2 | Adolescent health in India and South Africa |
Chairperson: Dr Ben Montoedi Ekurhuleni Dr Nirmalya Mukherjee: Director JBI-CPHR | |
14:00-14:10 | Challenges in Adolescent Health Dr Gwen Ramokgopa JBI-Ekurhuleni |
14:10-14:20 | Adolescent Reproductive health Dr Jayati Kusari JBI-Ekurhuleni |
14:20-14:30 | Adolescent health in tribal populations in India Dr. Krishnamurthy Jayanna (Ramaiah University of Applied Sciences), India |
14:30-15:00 | Panel discussion Q&A Dr Nirmalya Mukherjee: Director JBI-CPHR |
15:00-15:30 | TEA BREAK |
SESSION 3 | Global Evidence based Adolescent health care |
Chairperson: Prof Ekta Saroha (IIHMR) + Prof Ute Feucht JBI-Ekurhuleni | |
15:30-15:40 | Evidence based health care and its application in Adolescent health Prof Denny John: Co-Director JBI-CPHR |
15:40-15:50 | Indigenous Adolescent health promotion through community media Dr Nirmalya Mukherjee: Director JBI-CPHR |
15:50-16:00 | Tshwane case study Mr Andani Singo JBI-Ekurhuleni |
16:00-16:10 | Kolkata case study Ms Sunita Kar Rescue and Relief Foundation, India |
16:10-16:40 | Panel discussion Q&A Prof Ute Feucht JBI-Ekurhuleni |
16:40-17:00 | Closing remarks Dr Paramita Bhattacharya JBI-CPHR |
Inaugural Event Of The Only JBI Affiliated Research Training Center In Eastern India
The Centre for Public Health Research (CPHR), MANT, marked a significant milestone with the successful organization of the inaugural program for the JBI Affiliate Centre on Evidence Synthesis and Evidence Implementation for Indigenous Health. Held on 11th March at Hotel The Sojourn, Salt Lake City, Kolkata, the event brought together esteemed speakers, experts, and stakeholders to discuss the crucial role of evidence synthesis and implementation in improving indigenous health.
Event Highlights:
Dr. Paramita Bhattacharya, Core Committee member of the JBI Affiliated Centre, commenced the session by introducing the distinguished speakers for the event, including Dr. Nirmalya Mukherjee, Prof Denny John, Dr. Barun Kanjilal, Prof. Debashis Basu, Dr. Chandrashekhar Janakiraman, and Dr. Jaideep Menon.
Introduction to Evidence Synthesis and Evidence Implementation in Indigenous Health by Prof Denny John:
Prof. John emphasized the importance of evidence-based decisions in healthcare and the immense potential of MANT in addressing indigenous health challenges. He proudly announced the establishment of the 5th JBI Affiliate Centre in India, leveraging MANT’s extensive experience and leadership.
Address by Chief Guest Prof Debashis Basu:
Prof. Basu, the Head of the Department of the Public Health Medical Unit at the University of Pretoria, emphasized the importance of resource optimization and collaboration among JBI Affiliate Centres worldwide. He discussed the responsibilities and challenges faced by public health researchers in contributing to policy-making decisions.
Address by Tribal Member Smt. Shreemanti Hembram:
Smt. Hembram, a tribal community representative, highlighted the potential of the research wing of MANT in articulating the needs and aspirations of indigenous people. She expressed hope for evidence-based programs to positively impact the health and well-being of future generations.
Welcome Address by Dr. Nirmalya Mukherjee:
Dr. Mukherjee provided a brief overview of MANT’s history and highlighted its mission to uplift the marginalized tribal population through educational institutions and various developmental initiatives. He expressed gratitude to mentors, executive committee members, and guests for their unwavering support.
Presidential Address by Dr. Barun Kanjilal:
Dr. Kanjilal, a health economist, applauded the focus on evidence synthesis and highlighted the transformative power of presenting evidence systematically. He stressed the need to bridge the gap between research and policy implementation for effective healthcare outcomes.
Address by Guests of Honour Dr. Chandrashekhar Janakiraman and Dr. Jaideep Menon:
Dr. Janakiraman commended MANT’s efforts in establishing the JBI Affiliate Centre and stressed the need to address gaps in evidence synthesis for effective policy formulation. Dr. Menon expressed interest in collaborating with MANT, recognizing the significance of tribal health research and the shared focus on serving marginalized communities.
Conclusion:
The inaugural event of the JBI Affiliate Centre on Evidence Synthesis and Implementation for Indigenous Health served as a momentous occasion in furthering MANT’s commitment to improving indigenous health. The insightful speeches, valuable discussions, and shared aspirations for evidence-based healthcare and policy implementation set the stage for a future marked by impactful research and transformative outcomes.
Related Articles
MANT-PSC Stakeholder Consultation Workshop
Bridging the Healthcare Gap: Insights from National Symposium on Tribal Health 2023
At the National Symposium on Tribal Health, held on December 15, 2023, language barriers took center stage as a critical hurdle in healthcare delivery to India’s tribal communities. Proposed solutions, such as training bilingual mediators, aimed to bridge the communication gap. The symposium also unveiled alarming statistics on non-communicable diseases among tribal populations, challenging stereotypes. Notably, the event showcased the annual report of CPHR-MANT, underlining a commitment to transparency. Covered by popular media, the symposium heightened awareness, emphasizing the pressing need for inclusive healthcare solutions tailored to the unique challenges faced by tribal communities.
Mental Health at Crossroads: Challenges and Solutions from India and South Africa
WEBINARMental Health at Crossroads: Challenges and Solutions from India and South AfricaEvent Date: September 8, 2023 Time: 1:30 PM - 5:20 PM (IST) 10 AM - 2 PM (SAST) The proposational contribution of mental disorders to total disease burden in India has almost...
Stay Up to Date With The Latest News & Updates
Join Our Newsletter
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque
Follow Us
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque
Health Technology Assessment Research Unit
Health Technology Assessment Research Unit
Health technology assessment (HTA) is a structured analysis of a health technology, a set of related technologies, or a technology-related issue that is performed for the purpose of providing input to a policy decision (US Congress, Office of Technology Assessment 1994). HTA asks important questions about these technologies [drugs, devices, procedures, settings of care, screening] such as: When is counselling better than drug treatment for depression? Should we screen for human papilloma virus when doing cervical smears? Should aspirin be used for the primary prevention of cardiovascular disease? It answers these questions by investigating four main factors: whether the technology works, for whom, at what cost, how it compares with the alternatives (UK NHS National Institute for Health Research Health Technology Assessment Programme 2013).
HTA is a field of scientific research to inform policy and clinical decision making around the introduction and diffusion of health technologies. HTA is a multidisciplinary field that addresses the health impacts of technology, considering its specific healthcare context as well as available alternatives. Contextual factors addressed by HTA include economic, organizational, social, and ethical impacts. The scope and methods of HTA may be adapted to respond to the policy needs of a particular health system (Health Technology Assessment International 2013).
CPHR’s team with expertise in clinical trials, epidemiology, biostatistics, and economic modelling are currently involved in several projects aimed at evidence to inform policy and practice in the areas of digital health technologies, and health services.
Subscribe
Book a Free 30min Consultation
Model-based estimation of burden of COVID-19 with disability-adjusted life years and value of statistical life in West Bengal, India
COVID-19 had a higher impact on the elderly population with 90.2% of deaths arising from people aged above 45.
Our research found that DALYs for males and females were 190 568.1 and 117 310.0 years, respectively, and the YPPLL of the productive population was 28 714.7 and 16 355.4 years. The CPL due to premature mortality was INR3 198 259 615.6 and INR583 397 335.1 for males and females, respectively, while the CPL due to morbidity was INR2 505 568 048.4 and INR763 720 886.1. YPLL for males and females ranged from 189 103.2 to 272 787.5 years and 117 925.5 to 169 712.0 years for lower to higher age limits, and WYPLL was 54 333.9 and 30 942.2 years. The VSL (INR million) for the lower, midpoint, and upper life expectancies was 883 330.8, 882 936.4, and 880 631.3, respectively.
Our study found that vaccination was associated with reduced mortality. The losses incurred due to COVID-19 had a disproportionately higher impact on the elderly and males in West Bengal. Analyzing various age-gender subgroups enhances localized and targeted policymaking to minimize losses in future pandemics.
Based on the gathered data on infections and deaths
In Kerala, the impact of the virus was less severe on young people compared to the elderly, and this was also evident in our study. Despite the infection rate being 28.0% and 25.8% among males and females in the 31-45 years age group, respectively, the percentage of deaths in this group was only 8.4% and 6.8% of the total deaths.
Stay Up to Date With The Latest News & Updates
Join Our Newsletter
We share interesting and well-researched facts about the Public Health situation in India and World wide.